Search - tctmd.com

Displaying 121 - 140 of 540

Sort: Relevancy | Date

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Daily News

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

Presentation TVT 2020

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Presenter: Tsuyoshi Kaneko

June 20, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Presenter: Guilherme F. Attizzani

June 20, 2020

News Daily News

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

L.A. McKeown

June 16, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Conference News ACC 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

L.A. McKeown

April 07, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Daily News

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

Todd Neale

January 29, 2020

Advertisement

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Device Explants After TAVR Rare but Risky

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content